Last reviewed · How we verify

NCT06206161: OASIS

Optimizing and Advancing SBIRT in Schools

ENROLLING BY INVITATION NA Last updated 26 November 2025
What this trial tests

NA trial testing Indicated Prevention, Clinical Staff in Adolescent Drinking in 21,000 participants. Enrolling by invitation.

Timeline
11 October 2023
Primary endpoint
11 November 2027
11 November 2027

Quick facts

Lead sponsorMassachusetts General Hospital
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment21,000
Start date11 October 2023
Primary completion11 November 2027
Estimated completion11 November 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Massachusetts General Hospital

Who can join

Adults 14 to 19, any sex, with Adolescent Drinking or Adolescent Substance Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to establish whether brief interventions for alcohol use can be delivered in schools for both indicated prevention and selected prevention, determine if an expanded workforce is an effective model for screening, brief intervention, and referral to treatment (SBIRT) delivery in schools, and explore whether brief intervention effectiveness is comparable in minoritized versus non-minoritized adolescents. Participants will be students at high schools across Massachusetts. High schools will be randomized to one of four intervention groups. Participants will complete a baseline survey prior to their school-wide screening for SBIRT, and then will complete four follow-up surveys over two years.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Adolescent Drinking

Currently open trials in the same condition.

Other Massachusetts General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06206161.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing